What semaglutide does and how it works
Semaglutide is a medication that mimics glucagon-like peptide-1 (GLP-1), a hormone your body makes naturally after eating. It slows how fast your stomach empties, increases insulin release when blood sugar rises, and signals your brain that you feel full—all of which lower appetite and reduce how much you eat. The drug was originally developed to treat type 2 diabetes and is sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss). It is now also used off-label by people seeking performance or body composition changes.
The mechanism is well-established in human trials. When you inject semaglutide once weekly, it binds to GLP-1 receptors throughout your digestive system and brain. This triggers a cascade: your pancreas releases more insulin, your liver reduces glucose production, and your hypothalamus—the brain region that controls hunger—receives a stronger "full" signal. The net effect is lower calorie intake without requiring willpower alone. Studies show people on semaglutide eat roughly 20 to 30 percent fewer calories than they did before, mostly because they feel satisfied sooner and think about food less often.
Key Takeaways
- Semaglutide works by slowing stomach emptying, boosting insulin, and signaling fullness to the brain—effects proven in human clinical trials over multiple years.
- Weight loss on semaglutide averages 10 to 15 percent of body weight in people without diabetes, with most loss occurring in the first six months.
- Common side effects include nausea, vomiting, and diarrhea, especially when starting or increasing the dose, and these often improve over weeks to months.
- Semaglutide does not work if you stop taking it; weight typically returns within months unless diet and exercise habits have changed permanently.
- The drug carries rare but serious risks including pancreatitis, gallbladder problems, and a possible link to thyroid cancer in animal studies—reasons why medical supervision is necessary.
Weight loss and body composition changes in human studies
The strongest evidence for semaglutide comes from randomized controlled trials in people without diabetes. The STEP trials (Semaglutide Treatment Effect in People with obesity) enrolled over 4,500 participants across four studies. Participants who received semaglutide 2.4 mg weekly lost an average of 10 to 15 percent of their starting body weight over 68 weeks, compared to 2 to 3 percent in the placebo group. Roughly 50 to 60 percent of people on semaglutide lost at least 10 percent of their body weight; about 35 percent lost 15 percent or more.
Most weight loss happens in the first 16 to 20 weeks, then slows. The loss comes primarily from fat rather than muscle, though some muscle loss does occur—one reason why resistance training during semaglutide use is recommended. People also see improvements in blood pressure, triglycerides, and fasting glucose, even without diabetes. These metabolic changes persist as long as the medication is taken, but reverse within weeks to months after stopping.
Common side effects and how they typically progress
Nausea is the most frequent side effect, occurring in 25 to 40 percent of people on the higher doses. It is usually mild to moderate and peaks in the first two weeks after a dose increase, then improves as your body adapts. Vomiting, constipation, and diarrhea occur in 10 to 20 percent of users. Dizziness, fatigue, and headache are reported but less common. Most people who experience nausea find it manageable—eating smaller meals, avoiding fatty foods, and staying hydrated help. Taking the injection on an evening when you can rest may also reduce symptoms.
Gastrointestinal side effects usually fade within four to eight weeks at a stable dose. However, if you increase the dose too quickly or if your stomach is particularly sensitive, symptoms can persist or worsen. This is why doctors start at a low dose (0.25 mg) and increase gradually every four weeks. If side effects become intolerable, your doctor can pause the dose increase, lower the dose, or stop the medication. Stopping abruptly does not cause withdrawal, but appetite returns quickly.
Serious risks that require medical monitoring
Pancreatitis—inflammation of the pancreas—is rare but documented in semaglutide users. It occurs in roughly 0.1 to 0.2 percent of people and usually appears as sudden severe abdominal pain, often radiating to the back, sometimes with vomiting. If you develop these symptoms, seek emergency care when ready. Gallbladder problems, including gallstones and cholecystitis, occur more often on semaglutide than in the general population, likely because rapid weight loss increases gallstone risk. Symptoms include pain in the upper right abdomen, especially after eating fatty food.
Animal studies have shown a dose-dependent increase in thyroid C-cell tumors in rats and mice exposed to semaglutide. Whether this translates to human thyroid cancer risk is unknown—no human cases have been causally linked to the drug, and the doses used in animals were much higher than those used in people. However, semaglutide is contraindicated (should not be used) in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Diabetic retinopathy (eye damage) can worsen in people with existing diabetes when blood sugar drops rapidly, though this is not a concern in non-diabetic users.
What happens when you stop taking semaglutide
Semaglutide does not produce lasting weight loss on its own. Once you stop injecting, the drug leaves your system within one to two weeks, and appetite returns to baseline. In clinical trials, people who stopped semaglutide regained roughly 50 to 70 percent of the weight they had lost within one year. Some people maintain a portion of their loss if they have genuinely changed their eating habits and exercise patterns during treatment, but the medication itself does not reprogram your metabolism permanently.
This means semaglutide is best thought of as a tool to help you lose weight and establish new habits while you are taking it, not as a one-time fix. Some people use it for a defined period—six months to two years—and then maintain through diet and exercise. Others take it long-term, similar to how someone might take a blood pressure medication indefinitely. The choice depends on your goals, how much weight returns when you stop, and whether the benefits justify the cost and ongoing injections.
How semaglutide compares to other weight loss medications
Semaglutide is more effective than older medications like phentermine (an amphetamine-like stimulant) or orlistat (which blocks fat absorption). Phentermine causes 5 to 10 percent weight loss over three to six months and carries cardiovascular risks; it is approved only for short-term use. Orlistat causes 3 to 5 percent weight loss and causes oily stools and urgency. Semaglutide's 10 to 15 percent loss is substantially larger, though it comes with more gastrointestinal side effects and higher cost.
Tirzepatide (Zepbound, Mounjaro) is a newer dual GLP-1 and GIP receptor agonist that shows slightly higher weight loss—up to 20 percent in some trials—but has a similar side effect profile and is not yet as widely available. Both semaglutide and tirzepatide require weekly injections and ongoing medical supervision. Neither is a substitute for diet and exercise, but both make it substantially easier to eat less while you are taking them.
Cost, access, and medical supervision requirements
Semaglutide is expensive. The brand-name Wegovy costs roughly $900 to $1,300 per month without insurance, though prices vary by pharmacy and region. Some insurance plans cover it for weight loss if you meet specific criteria (usually a BMI over 30, or over 27 with weight-related health conditions), but many do not. Generic versions are not yet available in the United States, though some countries have approved lower-cost alternatives. GoodRx and similar discount programs can reduce the price, but even discounted semaglutide typically costs $200 to $400 per month.
You cannot obtain semaglutide without a prescription from a licensed doctor or nurse practitioner. Legitimate prescribers will take a medical history, check for contraindications (especially thyroid cancer risk), and monitor you with periodic check-ins. Telehealth services and weight loss clinics can prescribe it, but be cautious of providers who do not ask detailed questions or who do not follow up. Compounded versions (made by pharmacies rather than manufacturers) exist but are not FDA-approved and may have inconsistent potency. Buying semaglutide without a prescription from online sources is illegal and carries the risk of counterfeit or contaminated product.
Frequently Asked Questions
Does semaglutide work if you have diabetes?
Yes. Semaglutide was originally approved for type 2 diabetes and is highly effective at lowering blood sugar and A1C. Weight loss is typically similar to non-diabetic users, though the blood sugar benefit is the primary reason for use in this population. If you have diabetes and take other medications, your doctor may need to adjust doses as semaglutide lowers blood sugar.
Can you build a tolerance to semaglutide?
Tolerance is not well-documented in clinical trials. Most people maintain steady weight loss as long as they continue the medication at the same dose. However, some people report that appetite gradually returns over months or years, which may reflect adaptation rather than true tolerance. If this happens, your doctor can discuss whether a dose increase is appropriate.
Is semaglutide safe for long-term use?
Long-term safety data extends to about three years in published trials, and no major new risks have emerged beyond those seen in shorter studies. However, decades-long data do not exist. Anyone considering long-term use should have regular medical check-ins, including blood work and screening for pancreatitis or gallbladder symptoms. The decision to use it long-term should be made with your doctor based on your individual health profile.
What happens to loose skin after weight loss on semaglutide?
Loose skin is a common result of rapid weight loss, regardless of the method. Semaglutide does not prevent this. The amount of loose skin depends on your age, how much weight you lose, and your skin's elasticity. Some people find it improves over time as skin retracts; others pursue surgical options. This is a cosmetic concern, not a medical one, and is not addressed by the medication itself.
Can you drink alcohol while taking semaglutide?
Moderate alcohol use is generally considered safe, but alcohol can worsen nausea and may cause blood sugar to drop more sharply. If you have diabetes, alcohol increases hypoglycemia risk. It is best to discuss your specific situation with your doctor, especially if you drink regularly or have a history of alcohol use disorder.